by Clinical Neuropsychologist | Thursday, September 5, 2024 | Neurology
No abstract available If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 5, 2024 Neurology Today – Current Issue Previous...
by Clinical Neuropsychologist | Thursday, September 5, 2024 | Neurology
No abstract available If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 5, 2024 Neurology Today – Current Issue Previous...
by Clinical Neuropsychologist | Friday, August 16, 2024 | Neurology
Background Health-related quality of life (Hr-QoL) scales provide crucial information on neurodegenerative disease progression, help improve patient care and constitute a meaningful endpoint for therapeutic research. However, Hr-QoL progression is usually poorly...
by Clinical Neuropsychologist | Friday, August 16, 2024 | Neurology
Background Disease-modifying therapies (DMTs) for Alzheimer’s disease (AD) have early evidence of efficacy. Widespread delivery of DMTs will require major service reconfiguration. Treatment pathways will need to include triaging for eligibility, regular infusions and...
by Clinical Neuropsychologist | Friday, August 16, 2024 | Neurology
Two publications in JNNP explore the potential utility of therapies with differing mechanisms of action for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Querol et al evaluate the neonatal Fc receptor blocker rozanolixizumab, while...
by Clinical Neuropsychologist | Friday, August 16, 2024 | Neurology
Driving a motor vehicle is an important skill set. Its evaluation is relevant to patients who had a stroke. These patients struggle to get back to driving because of physical deficits, including challenges from neglect and apraxia and the risk of unexpected future...
